CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (486)	12/29/1998 2:12:00 PM
From: Mike McFarland	Read Replies (1) of 675

Thread: Anybody have any idea about how large might be the subset of stroke patients who might benefit from Cerestat? Or is it called aptiganel...anyway, since cnsi has all the rights to it now it is worth a review. Although if Boehringer Ingelheim didn't see anything in the data that looked particularly profitable, what is it that cnsi sees? In other news cnsi only down 1/32 today, although we are running out of 32nds... geeze if this thing goes all the way back to fifty cents I'm going to look like such an idiot. (Even more than now). --Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next